<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="3" total-samples="130" total-assays="130"><experiment><id>540922</id><accession>E-GEOD-79670</accession><secondaryaccession>GSE79670</secondaryaccession><name>RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for *ANGPTL4*</name><releasedate>2016-06-11</releasedate><lastupdatedate>2016-06-18</lastupdatedate><organism>Homo sapiens</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>This SuperSeries is composed of the SubSeries listed below. Refer to individual Series</text></description><provider><contact>Marie K Kirby</contact><role>submitter</role><email>geo@ncbi.nlm.nih.gov</email></provider><bibliography><accession>27282075</accession><authors>Kirby MK, Ramaker RC, Gertz J, Davis NS, Johnston BE, Oliver PG, Sexton KC, Greeno EW, Christein JD, Heslin MJ, Posey JA, Grizzle WE, Vickers SM, Buchsbaum DJ, Cooper SJ, Myers RM</authors><title>RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.</title><doi>10.1016/j.molonc.2016.05.004</doi></bibliography><samplecharacteristic><category>age</category><value>28</value><value>44</value><value>45</value><value>46</value><value>49</value><value>51</value><value>53</value><value>54</value><value>56</value><value>57</value><value>59</value><value>60</value><value>62</value><value>63</value><value>64</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>76</value><value>77</value><value>78</value><value>79</value><value>85</value></samplecharacteristic><samplecharacteristic><category>cell line</category><value>AsPC-1</value><value>Capan-1</value><value>Capan-2</value><value>CFPAC-1</value><value>HPAF-II</value><value>L3.6pl</value><value>Panc 02.03</value><value>PANC 6.03</value><value>PANC-1</value><value>S2-013</value><value>S2-LM7-AA</value><value>S2-LM7-YB</value><value>S2VP10</value><value>SUIT-2</value></samplecharacteristic><samplecharacteristic><category>diabetes status</category><value>no</value><value>yes</value></samplecharacteristic><samplecharacteristic><category>gemcitabine sensitivity</category><value>Resistant</value><value>Sensitive</value></samplecharacteristic><samplecharacteristic><category>m tnm score</category><value>M0</value><value>M1</value><value>MX</value></samplecharacteristic><samplecharacteristic><category>n tnm score</category><value>N0</value><value>N1</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>patient gender</category><value>female</value><value>male</value></samplecharacteristic><samplecharacteristic><category>patient race</category><value>Black</value><value>NA</value><value>White</value></samplecharacteristic><samplecharacteristic><category>patient survival status</category><value>alive</value><value>dead</value></samplecharacteristic><samplecharacteristic><category>survival time days</category><value>1113</value><value>1230</value><value>1440</value><value>1454</value><value>1505</value><value>1544</value><value>1554</value><value>1564</value><value>161</value><value>189</value><value>199</value><value>210</value><value>222</value><value>235</value><value>244</value><value>256</value><value>279</value><value>2906</value><value>291</value><value>293</value><value>2995</value><value>30</value><value>311</value><value>3163</value><value>3169</value><value>36</value><value>371</value><value>393</value><value>424</value><value>432</value><value>449</value><value>477</value><value>543</value><value>553</value><value>557</value><value>561</value><value>572</value><value>589</value><value>592</value><value>610</value><value>621</value><value>629</value><value>642</value><value>647</value><value>67</value><value>697</value><value>702</value><value>734</value><value>741</value><value>809</value><value>975</value></samplecharacteristic><samplecharacteristic><category>t tnm score</category><value>T1</value><value>T2</value><value>T3</value><value>T4</value></samplecharacteristic><experimentalvariable><name>age</name><value>28</value><value>44</value><value>45</value><value>46</value><value>49</value><value>51</value><value>53</value><value>54</value><value>56</value><value>57</value><value>59</value><value>60</value><value>62</value><value>63</value><value>64</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>76</value><value>77</value><value>78</value><value>79</value><value>85</value><value>not specified</value></experimentalvariable><experimentalvariable><name>cell line</name><value>AsPC-1</value><value>Capan-1</value><value>Capan-2</value><value>CFPAC-1</value><value>HPAF-II</value><value>L3.6pl</value><value>not specified</value><value>Panc 02.03</value><value>PANC 6.03</value><value>PANC-1</value><value>S2-013</value><value>S2-LM7-AA</value><value>S2-LM7-YB</value><value>S2VP10</value><value>SUIT-2</value></experimentalvariable><experimentalvariable><name>diabetes status</name><value>no</value><value>not specified</value><value>yes</value></experimentalvariable><experimentalvariable><name>gemcitabine sensitivity</name><value>not specified</value><value>Resistant</value><value>Sensitive</value></experimentalvariable><experimentalvariable><name>m tnm score</name><value>M0</value><value>M1</value><value>MX</value><value>not specified</value></experimentalvariable><experimentalvariable><name>n tnm score</name><value>N0</value><value>N1</value><value>not specified</value></experimentalvariable><experimentalvariable><name>patient gender</name><value>female</value><value>male</value><value>not specified</value></experimentalvariable><experimentalvariable><name>patient race</name><value>Black</value><value>NA</value><value>not specified</value><value>White</value></experimentalvariable><experimentalvariable><name>patient survival status</name><value>alive</value><value>dead</value><value>not specified</value></experimentalvariable><experimentalvariable><name>survival time days</name><value>1113</value><value>1230</value><value>1440</value><value>1454</value><value>1505</value><value>1544</value><value>1554</value><value>1564</value><value>161</value><value>189</value><value>199</value><value>210</value><value>222</value><value>235</value><value>244</value><value>256</value><value>279</value><value>2906</value><value>291</value><value>293</value><value>2995</value><value>30</value><value>311</value><value>3163</value><value>3169</value><value>36</value><value>371</value><value>393</value><value>424</value><value>432</value><value>449</value><value>477</value><value>543</value><value>553</value><value>557</value><value>561</value><value>572</value><value>589</value><value>592</value><value>610</value><value>621</value><value>629</value><value>642</value><value>647</value><value>67</value><value>697</value><value>702</value><value>734</value><value>741</value><value>809</value><value>975</value><value>not specified</value></experimentalvariable><experimentalvariable><name>t tnm score</name><value>not specified</value><value>T1</value><value>T2</value><value>T3</value><value>T4</value></experimentalvariable><protocol><id>1204954</id><accession>P-GSE79670-4</accession></protocol><protocol><id>1204953</id><accession>P-GSE79670-3</accession></protocol><protocol><id>1204952</id><accession>P-GSE79670-2</accession></protocol><protocol><id>1204955</id><accession>P-GSE79670-1</accession></protocol></experiment><experiment><id>540921</id><accession>E-GEOD-79669</accession><secondaryaccession>SRP072493</secondaryaccession><secondaryaccession>GSE79669</secondaryaccession><name>RNA sequencing of human pancreatic cancer cell lines</name><releasedate>2016-06-11</releasedate><lastupdatedate>2016-06-18</lastupdatedate><organism>Homo sapiens</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>RNA-seq profiling was conducted on human pancreatic cancer cell lines We measured the transcriptome in 14 human pancreatic cancer cell linees</text></description><provider><contact>Ryne C Ramaker</contact><role/><email/></provider><provider><contact>Sara J Cooper</contact><role/><email/></provider><provider><contact>Richard M Myers</contact><role/><email/></provider><provider><contact>Marie K Kirby</contact><role/><email/></provider><provider><contact>Donald J Buchsbaum</contact><role/><email/></provider><provider><contact>Patsy G Oliver</contact><role/><email/></provider><provider><contact>Marie K Kirby</contact><role>submitter</role><email>geo@ncbi.nlm.nih.gov</email></provider><bibliography><accession>27282075</accession><authors>Kirby MK, Ramaker RC, Gertz J, Davis NS, Johnston BE, Oliver PG, Sexton KC, Greeno EW, Christein JD, Heslin MJ, Posey JA, Grizzle WE, Vickers SM, Buchsbaum DJ, Cooper SJ, Myers RM</authors><title>RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.</title><doi>10.1016/j.molonc.2016.05.004</doi></bibliography><samplecharacteristic><category>cell line</category><value>AsPC-1</value><value>Capan-1</value><value>Capan-2</value><value>CFPAC-1</value><value>HPAF-II</value><value>L3.6pl</value><value>Panc 02.03</value><value>PANC 6.03</value><value>PANC-1</value><value>S2-013</value><value>S2-LM7-AA</value><value>S2-LM7-YB</value><value>S2VP10</value><value>SUIT-2</value></samplecharacteristic><samplecharacteristic><category>gemcitabine sensitivity</category><value>Resistant</value><value>Sensitive</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><experimentalvariable><name>cell line</name><value>AsPC-1</value><value>Capan-1</value><value>Capan-2</value><value>CFPAC-1</value><value>HPAF-II</value><value>L3.6pl</value><value>Panc 02.03</value><value>PANC 6.03</value><value>PANC-1</value><value>S2-013</value><value>S2-LM7-AA</value><value>S2-LM7-YB</value><value>S2VP10</value><value>SUIT-2</value></experimentalvariable><experimentalvariable><name>gemcitabine sensitivity</name><value>Resistant</value><value>Sensitive</value></experimentalvariable><protocol><id>1204949</id><accession>P-GSE79669-3</accession></protocol><protocol><id>1204950</id><accession>P-GSE79669-2</accession></protocol><protocol><id>1204951</id><accession>P-GSE79669-1</accession></protocol><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>28</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>28</bioassays><isderived>0</isderived></bioassaydatagroup></experiment><experiment><id>540923</id><accession>E-GEOD-79668</accession><secondaryaccession>SRP072492</secondaryaccession><secondaryaccession>GSE79668</secondaryaccession><name>RNA-sequencing of human pancreatic adenocarcinoma cancer tissues</name><releasedate>2016-06-11</releasedate><lastupdatedate>2016-06-18</lastupdatedate><organism>Homo sapiens</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>RNA-seq profiling was conducted on clinically-annotated human pancreatic adenocarcinoma cancer tissues We measured the transcriptome in 51 clinically-annotated human pancreatic adenocarcinoma cancer tissues</text></description><provider><contact>William E Grizzle</contact><role/><email/></provider><provider><contact>Richard M Myers</contact><role/><email/></provider><provider><contact>James A Posey</contact><role/><email/></provider><provider><contact>Ryne C Ramaker</contact><role/><email/></provider><provider><contact>Selwyn M Vickers</contact><role/><email/></provider><provider><contact>Sara J Cooper</contact><role/><email/></provider><provider><contact>Donald J Buchsbaum</contact><role/><email/></provider><provider><contact>Marie K Kirby</contact><role>submitter</role><email>geo@ncbi.nlm.nih.gov</email></provider><bibliography><accession>27282075</accession><authors>Kirby MK, Ramaker RC, Gertz J, Davis NS, Johnston BE, Oliver PG, Sexton KC, Greeno EW, Christein JD, Heslin MJ, Posey JA, Grizzle WE, Vickers SM, Buchsbaum DJ, Cooper SJ, Myers RM</authors><title>RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.</title><doi>10.1016/j.molonc.2016.05.004</doi></bibliography><samplecharacteristic><category>age</category><value>28</value><value>44</value><value>45</value><value>46</value><value>49</value><value>51</value><value>53</value><value>54</value><value>56</value><value>57</value><value>59</value><value>60</value><value>62</value><value>63</value><value>64</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>76</value><value>77</value><value>78</value><value>79</value><value>85</value></samplecharacteristic><samplecharacteristic><category>diabetes status</category><value>no</value><value>yes</value></samplecharacteristic><samplecharacteristic><category>m tnm score</category><value>M0</value><value>M1</value><value>MX</value></samplecharacteristic><samplecharacteristic><category>n tnm score</category><value>N0</value><value>N1</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>patient gender</category><value>female</value><value>male</value></samplecharacteristic><samplecharacteristic><category>patient race</category><value>Black</value><value>NA</value><value>White</value></samplecharacteristic><samplecharacteristic><category>patient survival status</category><value>alive</value><value>dead</value></samplecharacteristic><samplecharacteristic><category>survival time days</category><value>1113</value><value>1230</value><value>1440</value><value>1454</value><value>1505</value><value>1544</value><value>1554</value><value>1564</value><value>161</value><value>189</value><value>199</value><value>210</value><value>222</value><value>235</value><value>244</value><value>256</value><value>279</value><value>2906</value><value>291</value><value>293</value><value>2995</value><value>30</value><value>311</value><value>3163</value><value>3169</value><value>36</value><value>371</value><value>393</value><value>424</value><value>432</value><value>449</value><value>477</value><value>543</value><value>553</value><value>557</value><value>561</value><value>572</value><value>589</value><value>592</value><value>610</value><value>621</value><value>629</value><value>642</value><value>647</value><value>67</value><value>697</value><value>702</value><value>734</value><value>741</value><value>809</value><value>975</value></samplecharacteristic><samplecharacteristic><category>t tnm score</category><value>T1</value><value>T2</value><value>T3</value><value>T4</value></samplecharacteristic><experimentalvariable><name>age</name><value>28</value><value>44</value><value>45</value><value>46</value><value>49</value><value>51</value><value>53</value><value>54</value><value>56</value><value>57</value><value>59</value><value>60</value><value>62</value><value>63</value><value>64</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>76</value><value>77</value><value>78</value><value>79</value><value>85</value></experimentalvariable><experimentalvariable><name>diabetes status</name><value>no</value><value>yes</value></experimentalvariable><experimentalvariable><name>m tnm score</name><value>M0</value><value>M1</value><value>MX</value></experimentalvariable><experimentalvariable><name>n tnm score</name><value>N0</value><value>N1</value></experimentalvariable><experimentalvariable><name>patient gender</name><value>female</value><value>male</value></experimentalvariable><experimentalvariable><name>patient race</name><value>Black</value><value>NA</value><value>White</value></experimentalvariable><experimentalvariable><name>patient survival status</name><value>alive</value><value>dead</value></experimentalvariable><experimentalvariable><name>survival time days</name><value>1113</value><value>1230</value><value>1440</value><value>1454</value><value>1505</value><value>1544</value><value>1554</value><value>1564</value><value>161</value><value>189</value><value>199</value><value>210</value><value>222</value><value>235</value><value>244</value><value>256</value><value>279</value><value>2906</value><value>291</value><value>293</value><value>2995</value><value>30</value><value>311</value><value>3163</value><value>3169</value><value>36</value><value>371</value><value>393</value><value>424</value><value>432</value><value>449</value><value>477</value><value>543</value><value>553</value><value>557</value><value>561</value><value>572</value><value>589</value><value>592</value><value>610</value><value>621</value><value>629</value><value>642</value><value>647</value><value>67</value><value>697</value><value>702</value><value>734</value><value>741</value><value>809</value><value>975</value></experimentalvariable><experimentalvariable><name>t tnm score</name><value>T1</value><value>T2</value><value>T3</value><value>T4</value></experimentalvariable><protocol><id>1204956</id><accession>P-GSE79668-4</accession></protocol><protocol><id>1204957</id><accession>P-GSE79668-3</accession></protocol><protocol><id>1204958</id><accession>P-GSE79668-2</accession></protocol><protocol><id>1204959</id><accession>P-GSE79668-1</accession></protocol><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>102</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>102</bioassays><isderived>0</isderived></bioassaydatagroup></experiment></experiments>